|
US2978453A
(en)
|
1956-12-12 |
1961-04-04 |
Aerojet General Co |
3, 3, 5, 5-tetranitropiperidine
|
|
JPS4830376B1
(cg-RX-API-DMAC7.html)
|
1970-12-29 |
1973-09-19 |
|
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
JPS5511509A
(en)
*
|
1978-07-07 |
1980-01-26 |
Toomasu Gorudon Robaato |
Cancer therapy
|
|
US4935450A
(en)
|
1982-09-17 |
1990-06-19 |
Therapeutical Systems Corporation |
Cancer therapy system for effecting oncolysis of malignant neoplasms
|
|
GB8504253D0
(en)
|
1985-02-19 |
1985-03-20 |
Ici Plc |
Electrostatic spraying apparatus
|
|
US4584130A
(en)
|
1985-03-29 |
1986-04-22 |
University Of Maryland |
Intramolecularly cross-linked hemoglobin and method of preparation
|
|
GB8728418D0
(en)
|
1987-12-04 |
1988-01-13 |
Jenkins T C |
Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
|
|
DE3815221C2
(de)
|
1988-05-04 |
1995-06-29 |
Gradinger F Hermes Pharma |
Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
|
|
US5693794A
(en)
|
1988-09-30 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Navy |
Caged polynitramine compound
|
|
JP2659614B2
(ja)
|
1990-11-13 |
1997-09-30 |
株式会社日立製作所 |
表示制御装置
|
|
TW198712B
(cg-RX-API-DMAC7.html)
|
1991-04-17 |
1993-01-21 |
Hoffmann La Roche |
|
|
US5698155A
(en)
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
WO1993008842A1
(en)
|
1991-11-08 |
1993-05-13 |
Somatogen, Inc. |
Hemoglobins as drug delivery agents
|
|
DE4226974C2
(de)
|
1992-08-14 |
1994-08-11 |
Fresenius Ag |
Verfahren und Vorrichtung zur kontinuierlichen Aufbereitung einer Zellsuspension
|
|
US5336784A
(en)
|
1993-06-07 |
1994-08-09 |
The Regents Of The University Of California |
Synthesis of 1,3,3-trinitroazetidine
|
|
ES2092460T3
(es)
|
1994-05-27 |
2001-02-01 |
Cellegy Pharma Inc |
Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
|
|
WO1996019198A1
(en)
|
1994-12-22 |
1996-06-27 |
Astra Aktiebolag |
Aerosol drug formulations
|
|
NZ304009A
(en)
|
1995-03-14 |
1999-02-25 |
Siemens Ag |
Ultrasonic atomizer device with a removable precision dosating unit
|
|
ES2177771T3
(es)
|
1995-03-14 |
2002-12-16 |
Siemens Ag |
Dispositivo atomizador ultrasonico con unidad desmontable de dosificacion de precision.
|
|
US5580988A
(en)
|
1995-05-15 |
1996-12-03 |
The United States Of America As Represented By The Secretary Of The Army |
Substituted azetidines and processes of using them
|
|
AU5798996A
(en)
|
1995-05-15 |
1996-11-29 |
Sachs, Michael C. |
Adnaz, compositions and processes
|
|
US5898038A
(en)
|
1996-03-19 |
1999-04-27 |
Board Of Regents, The University Of Texas System |
Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
|
|
EP0932598A1
(en)
|
1996-10-11 |
1999-08-04 |
Warner-Lambert Company |
ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
|
|
AU3129097A
(en)
|
1996-10-15 |
1998-05-11 |
Eastman Chemical Company |
Explosive formulations
|
|
US5945446A
(en)
|
1997-02-10 |
1999-08-31 |
Laubc Biochemicals, Corporation |
Process for preparing synthetic soil-extract materials and medicaments based thereon
|
|
HUP9701554D0
(en)
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
GB9720797D0
(en)
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
|
US5954047A
(en)
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
|
US6056966A
(en)
|
1998-05-18 |
2000-05-02 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for treating impotence
|
|
AU750313B2
(en)
|
1998-07-27 |
2002-07-18 |
St. Jude Pharmaceuticals, Inc. |
Chemically induced intracellular hyperthermia
|
|
US6448253B1
(en)
|
1998-09-16 |
2002-09-10 |
King Pharmaceuticals Research And Development, Inc. |
Adenosine A3 receptor modulators
|
|
US6391911B1
(en)
|
1999-02-26 |
2002-05-21 |
Robert E. Bases |
Coadministration of lucanthone and radiation for treatment of cancer
|
|
US20020077276A1
(en)
|
1999-04-27 |
2002-06-20 |
Fredeking Terry M. |
Compositions and methods for treating hemorrhagic virus infections and other disorders
|
|
US6245799B1
(en)
|
1999-11-08 |
2001-06-12 |
American Home Products Corp |
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
|
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
HRP20020808A2
(en)
|
2000-04-10 |
2004-12-31 |
Pfizer Prod Inc |
Benzoamide piperidine containing compounds and related compounds
|
|
US6861530B2
(en)
|
2000-07-07 |
2005-03-01 |
Kyowa Hakko Kogyo Co., Ltd. |
Piperidine derivatives
|
|
RU2188026C1
(ru)
|
2001-01-12 |
2002-08-27 |
Ростовский научно-исследовательский онкологический институт |
Способ лечения рака почки
|
|
DE10111049A1
(de)
|
2001-03-06 |
2002-09-12 |
Beiersdorf Ag |
Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
|
|
US20050070872A1
(en)
|
2001-12-28 |
2005-03-31 |
Kenichi Sato |
Blood bag system and method of inactivating pathogenic microorganisms
|
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
|
AU2003247792B2
(en)
|
2002-07-03 |
2009-09-24 |
Nicox S.A. |
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
AU2003282534A1
(en)
|
2002-10-07 |
2004-05-04 |
Radiorx, Inc. |
X-nitro compounds, pharmaceutical compositions thereof and uses therof
|
|
US6870061B2
(en)
|
2003-01-10 |
2005-03-22 |
Alliant Techsystems Inc. |
Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
|
|
AU2004237574A1
(en)
|
2003-03-13 |
2004-11-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds, compositions and methods of use
|
|
EP1646608B1
(en)
|
2003-06-25 |
2011-03-02 |
JE IL Pharmaceutical Co., Ltd. |
Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
|
|
US20040265238A1
(en)
|
2003-06-27 |
2004-12-30 |
Imtiaz Chaudry |
Inhalable formulations for treating pulmonary hypertension and methods of using same
|
|
WO2005004884A2
(en)
|
2003-07-09 |
2005-01-20 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Use of nitrite salts for the treatment of cardiovascular conditions
|
|
GB0326047D0
(en)
|
2003-11-07 |
2003-12-10 |
Univ Sheffield |
Substance
|
|
RU2265440C2
(ru)
|
2004-01-13 |
2005-12-10 |
Ростовский научно-исследовательский онкологический институт МЗ РФ |
Способ предоперационного лечения рака молочной железы
|
|
JP2008512490A
(ja)
|
2004-09-08 |
2008-04-24 |
チェルシー・セラピューティクス，インコーポレイテッド |
異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
|
|
US20060264415A1
(en)
|
2005-04-01 |
2006-11-23 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
US8367734B1
(en)
|
2005-08-11 |
2013-02-05 |
Amphastar Pharmaceuticals Inc. |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
BRPI0616755A2
(pt)
|
2005-09-27 |
2011-06-28 |
Novartis Ag |
compostos de carboxiamina e métodos de uso dos mesmos
|
|
FR2891843A1
(fr)
|
2005-10-06 |
2007-04-13 |
Erytech Pharma Soc Par Actions |
Erythrocytes contenant du 5-fluorouracile
|
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
CN200946766Y
(zh)
|
2006-06-09 |
2007-09-12 |
刘余厚 |
一种套管式紫外灯
|
|
US8122281B2
(en)
|
2007-04-13 |
2012-02-21 |
International Business Machines Corporation |
System and method for dependent failure-aware allocation of distributed data-processing systems
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
CA2721153C
(en)
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP2128133A1
(en)
|
2008-05-26 |
2009-12-02 |
Lek Pharmaceuticals D.D. |
Ezetimibe process and composition
|
|
EP2416790B1
(en)
|
2009-04-09 |
2018-05-23 |
Entegrion, Inc. |
Spray-dried blood products and methods of making same
|
|
EP2416650B1
(en)
|
2009-04-10 |
2020-02-26 |
Abraxis BioScience, LLC |
Nanoparticle formulations and uses therof
|
|
CN101708337B
(zh)
|
2009-08-18 |
2011-08-10 |
上海交通大学医学院附属新华医院 |
一种包载奥沙利铂的人血白蛋白纳米粒的制备方法
|
|
RU2411953C1
(ru)
|
2009-09-02 |
2011-02-20 |
Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт" Федерального агентства по высокотехнологичной мед. помощи |
Способ лечения рака молочной железы
|
|
US8471041B2
(en)
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
|
WO2012078992A1
(en)
*
|
2010-12-09 |
2012-06-14 |
Radiorx, Inc. |
Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto
|
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
|
US20140308260A1
(en)
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
ES2935573T3
(es)
|
2011-10-07 |
2023-03-08 |
Epicentrx Inc |
Compuestos de organonitro tioéter y usos médicos de estos
|
|
US8530461B2
(en)
|
2011-12-29 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
|
EP2687225A1
(en)
|
2012-07-19 |
2014-01-22 |
Alfact Innovation |
HIP/PAP protein and derivatives thereof for use in treating cancer
|
|
WO2014039960A1
(en)
|
2012-09-10 |
2014-03-13 |
Celgene Corporation |
Methods for the treatment of locally advanced breast cancer
|
|
CA2917403C
(en)
|
2013-08-27 |
2018-05-29 |
Halliburton Energy Services, Inc. |
Energetic cocrystals for treatment of a subterranean formation
|
|
US20140220163A1
(en)
|
2014-02-04 |
2014-08-07 |
Hamzeh Soleimani Babadi |
Powder mixture composition of natural materials for controlling deficiencies in polypeptide alpha and beta hemoglobin chains
|
|
FR3017299B1
(fr)
|
2014-02-12 |
2018-05-18 |
Erytech Pharma |
Composition pharmaceutique comprenant des erythrocytes encapsulant une enzyme a plp et son cofacteur
|
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
|
KR20190040931A
(ko)
|
2016-01-11 |
2019-04-19 |
에피센트알엑스, 인코포레이티드 |
2-브로모-1-(3,3-디니트로아제티딘-1-일)에타논의 정맥내 투여를 위한 조성물 및 방법
|
|
EP3526195A4
(en)
|
2016-10-14 |
2020-05-20 |
EpicentRx, Inc. |
SULFOXYALKYLE ORGANONITRO, RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN MEDICINE
|
|
IL271777B2
(en)
|
2017-07-07 |
2024-09-01 |
Epicentrx Inc |
Compositions for parenteral administration of therapeutic agents
|
|
US20200345689A1
(en)
|
2018-01-08 |
2020-11-05 |
Epicentrx, Inc. |
METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION
|
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
|
EP3801678A4
(en)
|
2018-06-11 |
2022-04-06 |
EpicentRx, Inc. |
MEDICATION INFUSION DEVICES, SYSTEMS AND METHODS
|
|
IL293672A
(en)
|
2019-12-11 |
2022-08-01 |
Epicentrx Inc |
Drug infusion devices, systems and methods
|
|
TW202228708A
(zh)
|
2020-09-29 |
2022-08-01 |
浩峰生物科技股份有限公司 |
樟芝酸ｈ與其衍生物用於治療神經系統疾病的用途
|
|
CN114621125B
(zh)
|
2020-12-14 |
2024-07-09 |
中国科学技术大学 |
Nlrp3炎症小体抑制剂及其应用
|
|
MX2023014676A
(es)
|
2021-06-09 |
2024-02-06 |
Epicentrx Inc |
Composiciones de abdnaz cristalinas y metodos de elaboracion y uso de estas.
|